Skip to main content

Table 1 Clinical characteristic of patients with STEMI according to glucometabolic classifications by an OGTT in-hospital and after three months

From: Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study

 

In-hospital

 

At three-month follow-up

 
 

NGR (n = 119)

AGR (n = 105)

P

NGR (n = 151)

AGR (n = 50)

P

Age (years)

55 (50,63)

60 (54,71)

<0.001

57 (51, 65)

61 (52, 72)

0.04

Men

106 (89.1)

79 (75.2)

<0.01

129 (85.4)

36 (72.0)

0.03

Previous disorders

      

Treated dyslipidaemia

11 (9.2)

9 (8.6)

0.86

15 (9.9)

4 (8.0)

0.47

Treated hypertension

25 (21)

33 (31.4)

0.32

38 (25.2)

17 (34.0)

0.23

Previous acute MI

9 (7.6)

7 (6.7)

0.08

10 (6.6)

4 (8.0)

0.48

Previous angina pectoris

5 (4.2)

2 (1.9)

0.33

6 (4.0)

1 (2.0)

0.45

Current smoker

65 (54.6)

44 (41.9)

0.06

67 (44.4)

24 (48.0)

0.66

Body mass index (kg/m2)

25.9 (24.5, 28.7)

26.1 (24.3, 28.6)

0.82

26.1 (24.4, 28.5)

25.7 (24.1, 28.7)

0.73

Waist circumference

100 (94, 107)

99 (94, 107)

0.86

101 (94, 107)

98 (94, 107)

0.92

Cholesterol (mmo/L)

5.2 (4.5, 5.8)

5.1 (4.4, 5.8)

0.52

4.1 (3.8, 4.6)

4.0 (3.6, 4.8)

0.43

LDL-cholesterol (mmol/L)

3.4 (2.7, 4.2)

3.3 (2.7, 4.0)

0.54

2.2 (1.8, 2.6)

2.1 (1.7, 2.6)

0.42

Triglycerides (mmo/L)

1.4 (1.0,1.8)

1.2 (0.9,1.8)

0.11

1.2 (0.9, 1.6)

1.2 (1.1, 1.6)

0.64

Stents

114 (95.8)

101 (96.2)

0.88

143 (94.7)

49 (98.0)

0.30

One-vessel disease

78 (65.5)

61 (58.1)

0.25

92 (60.9)

30 (60.0)

0.91

Left main disease

47 (39.5)

42 (40.0)

0.94

58 (38.4)

21 (42.0)

0.65

IIb/IIIa inhibitors

37 (31.1)

42 (40.0)

0.17

54 (35.8)

19 (38.0)

0.78

TnT peak value (ug/L)

4.47 (2.39, 7.32)

5.63 (2.78,10.89)

0.03

4.85 (2.45, 8.31)

4.97 (2.38, 10.25)

0.47

Measured at three-month.

      

LVEF1 (%)

64 (57, 70)

62 (52,69)

0.13

63.5 (56, 70)

63.5 (51, 69)

0.47

Infarct size2 (%)

9 (0, 25)

20 (4.5, 32)

<0.001

13 (0, 27)

21.5 (0, 43)

0.04

Medication at discharge from CCU and after three months.

      

Aspirin

119 (100)

105 (100)

 

150 (99.3)

50 (100)

0.57

Clopidogrel

118 (99.2)

104 (99.0)

0.93

143 (94.7)

46 (92.0)

0.49

β-blockers

96 (80.7)

85 (81.0)

0.96

142 (94.0)

46 (92.0)

0.61

Lipid lowering agents

118 (99.2)

103 (99.1)

0.49

146 (96.7)

48 (96.0)

0.82

ACEIs

19 (16)

17 (16.2)

0.96

52 (34.4)

17 (34.0)

0.96

ARBs

8 (6.7)

10 (9.5)

0.44

21 (13.9)

4 (8.0)

0.27

  1. Data are presented as median values (25, 75 percentiles) or proportions.
  2. ACEIs: angiotensin-converting enzyme inhibitors, AGR: abnormal glucose regulation, acute MI: acute myocardial infarction, ARBs: angiotensin receptor blockers, CCU: coronary care unit, NGR: normal glucose regulation, TnT peak level: serum peak level of cardiac specific Troponin T. 1,2Measured at three months by SPECT analysis, 1LVEF: left ventricular ejection fraction, 2infarct size in % of left ventricular mass.